Evidence map›Paper›PMID 39544770›Full record

ArticleAmerican journal of translational research2024

Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn's disease: correlation with disease severity and biologic efficacy.

Chen Xie, Wenwei Qian, Liyun Shang, Xin Wang, Jingwen Zhang, Xinxing Ma, Xueqin Pang, Lanxiang Zhu, Qinhua Xi, Yue Teng and 1 more

Abstract read
In one paragraph

Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chen XieDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Wenwei QianDepartment of General Surgery, The Fourth Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Liyun ShangDepartment of Nursing, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Xin WangDepartment of Geriatric Medicine, Suzhou Municipal Hospital Suzhou, Jiangsu, China.
Jingwen ZhangSuzhou Medical College of Soochow University Suzhou, Jiangsu, China.
Xinxing MaDepartment of Radiology, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Xueqin PangDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Lanxiang ZhuDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Qinhua XiDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Yue TengDepartment of Radiology, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.
Weichang ChenDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the prognostic value of body composition-related imaging parameters in assessing Crohn's disease (CD) severity and biological responses in Chinese patients.

methodsWe retrospectively analyzed electronic medical records and Computed tomography (CT) images from 117 CD patients, including 90 with sarcopenia and 27 without. We calculated subcutaneous fat area (SFA), visceral fat area, skeletal muscle area (SMA), mesenteric fat index (MFI), skeletal muscle index (SMI), and muscle attenuation (MA). CD Activity Index (CDAI) score and Simple Endoscopic Score for CD (SES-CD) were used to evaluate inflammation and biologic efficacy. Correlation and comparative analyses were performed to determine associations between imaging parameters and clinical data. Receiver operating characteristic curve analysis evaluated the predictive performance of combined body composition indicators.

resultsSarcopenia was associated with higher CDAI scores and lower body mass index, albumin, and hemoglobin levels but was not associated with SES-CD or rates of clinical/endoscopic remission or response to biologic therapy. SMI was inversely correlated with CDAI score and SES-CD and positively correlated with albumin and hemoglobin. Endoscopy responders had higher SMA, MFI, SMI, and MA than non-responders. SES-CD improvement was positively correlated with MFI and MA and negatively correlated with SFA. The combined analysis of SMI, MFI, and MA yielded an area under the curve of 0.743 for predicting endoscopic response to biologic therapies in CD patients.

conclusionsSMI may indicate CD severity, while MFI and MA could predict biologic response. Integrating multiple body composition parameters enhances treatment outcome evaluation, suggesting their potential utility in CD assessment.

Indexed as

biologic efficacybody compositioncomputed tomographyCrohn’s diseaseprognosis

Identifiers

PMID39544770
PMCPMC11558411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.